BUSINESSBLOOMBERG
WuXi AppTec Becomes Top Short Target as 80% Rally Draws Skeptics
Chinese biotech firm WuXi AppTec Co. has been a highly popular stock this year, but its recent substantial rally of 80% has begun to generate increasing skepticism from market observers.
Related Signal
Adjacent reporting
- WuXi AppTec’s 100% Stock Rally Defies Geopolitical Headwinds
- Chinese biotech giant Wuxi AppTec sees first-half earnings surge amid US scrutiny
- Chinese biotech giant Wuxi AppTec sees first-half earnings surge amid US scrutiny
- Wall Street funds back China’s WuXi AppTec as weight-loss drug orders soar
- Wall Street funds back China’s WuXi AppTec as weight-loss drug orders soar
- China AI Stocks’ 1000%-Plus Profit Gain May Fail to Revive Rally